Merck receives a priority review from the USFDA for Keytruda combined with concurrent radiochemotherapy for cervical cancer.

Published Date: 22 Sep 2023

Rahway: Outside of North America and the United States, Merck is known as MSD. S. The Food and Drug Administration (FDA) has granted approval for.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer mortality continuing to decline, says report

2.

Radionuclide-Containing Combo Slows Metastatic Prostate Cancer, Improves Survival

3.

Financial hardship common in patients with cancer

4.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

5.

Advancing Health in Africa


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot